|
(E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethanamine hydrochloride; trans-N-Methyl-N-(1-naphthylmethyl)-6,6-dimethylhept-2-en-4-ynylamine hydrochloride |
078628-80-5; 091161-71-6 (free base) |
C21H25N.ClH |
|
(8S,10S)-10-[[3-Amino-2,3,6-trideoxy-4-O-(2R-tetrahydro-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl]oxy]-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione; (8S-cis)-10-[[3-Amino-2,3,6-trideoxy-4-O-(tetrahydro-2H-pyran-2-yl)- |
072496-41-4 |
C32H37NO12 |
|
(±)-1-(p-Hydroxyphenoxy)-3-[2-(morpholinocarbonamido)ethylamino]-2-propanol hemifumarate; (±)-N-[2-[[2-Hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]-4-morpholinecarboxamide (E)-2-butenedioate(2:1) (salt) |
090730-93-1; 069630-19-9 ((1:1) salt); 081801-12-9 |
C16H25N3O5.C4H4O4 |
|
4-Hydroxy-2-methyl-N-2-pyridinyl-2H-thieno[2,3-e]-1,2-thiazine-3-carboxamide 1,1-dioxide |
059804-37-4 |
C13H11N3O4S2 |
|
1-(2-Nitroimidazol-1-yl)-3-(1-piperidinyl)-2-propanol |
070132-51-3; 070132-50-2 (free base) |
C11H18N4O3.ClH |
|
17alpha-Acetoxy-6-methyl-19-norpregna-4,6-diene-3,20-dione |
058652-20-3; 058691-88-6 (free base) |
C23H30O4 |
|
1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine; 2′-Deoxy-2′-fluoro-5-iodocytarabine; 4-Amino-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodo-2(1H)-pyrimidinone |
069123-90-6; 069124-05-6 (monoHCl) |
C9H11FIN3O4 |
|
p-Chloro-5-methoxyvalerophenone (E)-O-(2-aminoethyl)oxime; 1-(4-Chlorophenyl)-5-methoxy-1-pentanone (E)-O-(2-aminoethyl)oxime |
054739-19-4 |
C14H21ClN2O2 |
|
Disodium 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano[3,2-g]quinoline-2,8-dicarboxylate |
069049-74-7; 069049-73-6 (free acid) |
C19H15NO7.2Na |
|
1-Benzoyl-2-methylindole-3-acetic acid; 2-(1-Benzoyl-2-methylindol-3-yl)acetic acid |
016401-80-2 |
C18H15NO3 |